UK Companies House feature
BENCHMARK ANIMAL HEALTH LIMITED
Profile
- Company number
- 08872045
- Status
- Active
- Incorporation
- 2014-01-31
- Last accounts made up
- 2024-09-30
- Account category
- FULL
- Primary SIC
- 75000
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors' have reviewed the Group's forecast for a period of at least 12 months from the date of approval of the financial statements and concluded that the Company should be able to continue to operate as a going concern. Further details are provided in note 2 to the financial statements.”
Subsidiaries
- Benchmark Animal Health US, Inc · 100% held · US · Supply of health products
- Benchmark Animal Health Inc · 100% held · Canada · Supply of health products
- Benchmark R&D (Thailand) Limited · 100% held · Thailand · Veterinary services
- Benchmark Animal Health Chile SpA · 100% held · Chile · Supply of health products
Significant events
- “The Health division underwent a significant restructuring in FY24 to create a sustainable and profitable business, concentrating on the core sea lice solution, Salmosan® Vet, while maintaining the capability to deploy Ectosan® Vet and CleanTreat® in the future.”
- “Transitioned CleanTreat® from the PSV model to a future customer-owned infrastructure model, reducing fixed costs and capital exposure.”
- “Successfully demobilised both CleanTreat® PSVs in Q2 and Q3, leading to significant cost savings.”
- “capitalised development costs relating to Ectosan® Vet/CleanTreat® of £13.3m were impaired to nil.”
- “On 25 November, an agreement was signed for the Group to sell the whole Genetics business for consideration of up to £260m, with £230m received up front and up to £30m earnout receivable in three years. Completion of the deal took place on 31 March 2025”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
2 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HUGO, Pierre Joseph Jean | Director | 2025-09-30 | Dec 1971 | Belgian |
| ROSENLUND, Sindre Frivik | Director | 2025-09-30 | Jan 1992 | Norwegian |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BONNEY, Roland James | Director | 2014-01-31 | 2019-09-30 |
| DAVY, Christopher John | Director | 2017-01-05 | 2021-03-23 |
| KNOTT, Stephen Wesley Andrew | Director | 2018-10-02 | 2020-05-31 |
| MAGUIRE, Septima | Director | 2021-03-23 | 2025-07-31 |
| MARSHALL, John William | Director | 2014-01-31 | 2023-06-30 |
| MATHIASSEN, Fredrik Andre | Director | 2025-07-31 | 2025-09-30 |
| PLAMPIN, Mark James | Director | 2014-01-31 | 2019-12-20 |
| PYE, Malcolm David Foster | Director | 2014-01-31 | 2019-11-30 |
| WARDLE, Robin Glevum | Director | 2017-01-05 | 2019-07-02 |
| WILLIKSEN, Trond | Director | 2020-09-28 | 2025-08-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Benchmark Animal Health Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 75 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-11-06 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-10-03 | AP01 | officers | appoint person director company with name date |
| 2025-10-03 | TM01 | officers | termination director company with name termination date |
| 2025-10-03 | AP01 | officers | appoint person director company with name date |
| 2025-09-03 | TM01 | officers | termination director company with name termination date |
| 2025-08-01 | AP01 | officers | appoint person director company with name date |
| 2025-08-01 | TM01 | officers | termination director company with name termination date |
| 2025-07-07 | AA | accounts | accounts with accounts type full |
| 2025-04-02 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-12-09 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-12-09 | CH01 | officers | change person director company with change date |
| 2024-05-16 | AA | accounts | accounts with accounts type full |
| 2023-12-05 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-07-06 | AA | accounts | accounts with accounts type full |
| 2023-06-30 | TM01 | officers | termination director company with name termination date |
| 2022-12-05 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-11-29 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2022-11-24 | MR04 | mortgage | mortgage satisfy charge full |
| 2022-11-21 | CH01 | officers | change person director company with change date |
| 2022-11-14 | CH01 | officers | change person director company with change date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory